Clinical Trial Update: Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating avelumab plus 5-FU–based chemotherapy as adjuvant treatment for stage III colon cancer with POLE exonuclease mutation or microsatellite…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Microsatellite Instability Colorectal Cancer
• Pole Exonuclease Mutant Colon Cancer

Drugs mentioned

• 5-FU based chemotherapy (5-fluorouracil)
• Avelumab (avelumab)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: POLE Exonuclease Mutant Colon Cancer, Microsatellite Instability | Phase 3 | Status: TERMINATED